Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com
Advanced metastatic stage IIIB/IV NSCLC (Nonsquamous and squamous)
1 to 2 prior systemic therapies
Eastern Cooperative Oncology Group (ECOG) Performance Status of less than or equal to 1
Participants must have measurable disease by computed tomography (CT) or magnetic resonance imaging (MRI)
Prior radiotherapy or radiosurgery must have been completed at least 2 weeks prior to starting study treatment
You may not be if
Women with a positive pregnancy test at enrollment or prior to administration of study medication
Participants with active central nervous system metastases
Participants with a condition requiring systemic treatment with either corticosteroids (\> 10 mg daily prednisone equivalent) or other immunosuppressive medications within 14 days of first dose of study drug
Participants with previous malignancies are excluded unless a complete remission was achieved at least 2 years prior to study entry AND no additional therapy is required or anticipated to be required during the study period
Participants with carcinomatous meningitis
Clareo Health | A Study of Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Second-Line Nivolumab Monotherapy in Asia
